n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with morphine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jin, Y; Tian, W; Xi, J; Xu, Z; Zhang, L | 1 |
de la Torre-Madrid, E; Garzón, J; Rodríguez-Muñoz, M; Sánchez-Blázquez, P | 1 |
2 other study(ies) available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and morphine
Article | Year |
---|---|
Morphine prevents the mitochondrial permeability transition pore opening through NO/cGMP/PKG/Zn2+/GSK-3beta signal pathway in cardiomyocytes.
Topics: Analgesics, Opioid; Animals; Carbazoles; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Ethylenediamines; Fluorescent Dyes; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Models, Animal; Morphine; Myocytes, Cardiac; Nitric Oxide; Rats; Rats, Wistar; Signal Transduction; Zinc | 2010 |
NO-released zinc supports the simultaneous binding of Raf-1 and PKCγ cysteine-rich domains to HINT1 protein at the mu-opioid receptor.
Topics: Analgesics, Opioid; Animals; Chelating Agents; Ethylenediamines; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morphine; Naphthalenes; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Nitro Compounds; Protein Binding; Protein Kinase C; Protein Structure, Tertiary; Proto-Oncogene Proteins c-raf; Receptors, Opioid, mu; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Zinc | 2011 |